Seoul Yes Hospital (President Lee Gil-yong) and TS Bio (CEO Lee Hyung-seung), the largest shareholder of HLB Power, signed a Memorandum of Understanding (MOU) on the 23rd at the Seoul Yes Hospital main campus to collaborate on cell therapy research and development.

Based on their specialized knowledge and technical expertise, the two institutions agreed to actively pursue the commercialization of cell therapies through mutual cooperation and to launch TS Bio’s proprietary TCC (TS-Cell Complex) system at Seoul Yes Hospital.

TCC is a comprehensive system that oversees all cell therapies, encompassing diagnosis, cell isolation, storage, supply, and treatment conducted at TS Bio’s research institute and partner hospitals both domestically and internationally, within the scope of the Advanced Regenerative Medicine Act.

The two institutions agreed to collaborate on the construction of TCC facilities, the advancement of cell processing facilities, the collection and isolation of adipose-derived stem cells, technology transfer, education, and joint research on diseases related to spinal, joint, and muscle pain. They also agreed to cooperate in areas such as immunology, storage operations, and the provision of protocols for immunological testing and treatment.

They further stated that the long-term goal of the collaboration is to create a virtuous cycle by securing clinical data through the synergy between Seoul Yes Hospital’s MEST technology and the TCC system, thereby contributing to improving patients’ quality of life.

Cho Seong-hoon, President and Head of R&D at TS Bio, said, “We will share our vision for the future of regenerative medicine with Seoul Yes Hospital and collaborate to produce outstanding research results.”

Chief Director Lee Gil-yong remarked, “I hope the TCC system will serve as a ray of hope for patients suffering from the limitations of existing treatments.”

Meanwhile, to prevent the spread of COVID-19, the signing ceremony was attended by CEO Lee Hyung-seung, President Cho Seong-hoon, Chief Medical Officer Lee Gil-yong, and Seoul Yes Hospital Vice President Nam Jong-woo.